Targeted rnaseq improves clinical diagnosis of very early-onset pediatric immune dysregulation

HIGHLIGHTS

• who: Kiera Berger and collaborators from the School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USADivision of Bone Marrow Transplant, Children`s Healthcare of Atlanta, Emory University School of Medicine have published the research: Targeted RNAseq Improves Clinical Diagnosis of Very Early-Onset Pediatric Immune Dysregulation, in the Journal: (JOURNAL) of 26/07/2019
• what: The authors show that targeted RNAseq for a set of 13 PID and IBD patients resolves the likely source of immune dysfunction for at least eight patients, where previous exome analysis had only diagnosed three cases. While these . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.